Scyllo-Inositol is an inhibitor that targets the aggregation of misfolded proteins (such as alpha-synuclein and Amyloid-beta), is orally effective, and can cross the blood-brain barrier. Scyllo-Inositol can selectively bind to and stabilize non-toxic oligomers, preventing them from converting into toxic fibers, exerting protein homeostasis regulation and neuroprotective activity. Scyllo-Inositol binds to the hydrophobic region of pathogenic proteins, inhibits protein aggregation, and promotes lysosome- and proteasome-mediated degradation pathways, thereby reducing neurotoxicity. Scyllo-Inositol can be used in the study of neurodegenerative diseases such as Parkinsons disease, Alzheimers disease, and Huntingtons disease[1][2][3].
Molekulargewicht:
180.16
Reinheit:
99.99
CAS Nummer:
[488-59-5]
Formel:
C6H12O6
Target-Kategorie:
Amyloid-beta,alpha-synuclein
Anwendungsbeschreibung:
MCE Product type: Natural Products
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
